St. Louis-based Centene, the nation’s largest Medicaid managed care organization, is navigating a turbulent landscape as new federal policies threaten to reshape the safety net program. Leading the charge is Sarah London, 45, who remains the youngest woman to lead a Fortune 500 company. London is confronting significant funding cuts enacted under the “One Big Beautiful Bill Act,” championed by former President Trump, which slashes over $900 billion from federal Medicaid spending over the next decade and simultaneously increases costs for those relying on Affordable Care Act (ACA) Marketplace plans. The changes are already impacting Centene’s bottom line, and London is pushing for innovative solutions to maintain access to care for millions of Americans.
The financial strain is evident. While Centene reported nearly $194.8 billion in revenue in the last fiscal year, the company as well posted a net loss of $6.7 billion, largely due to a substantial write-down reflecting the new policy realities. As reported by Fortune in September 2025, the expiration of ACA subsidies and rising medical costs are creating significant headwinds for insurers like Centene.
London’s leadership is being tested not only by policy shifts but also by evolving enrollment trends. The company experienced a decline in enrollment in its ACA plans, coupled with a sicker patient population, prompting a withdrawal of earnings guidance last July. This decision triggered a 40% drop in Centene’s share price, reaching an eight-year low. “It’s hard not to feel like pulling guidance and cutting the stock in half is a failure,” London acknowledged in an interview with Fortune. “We’ve watched a new normal unfold in terms of how many different pressures there are on the system and the magnitude of the change we’re facing.”
Navigating a Shifting Landscape
Centene’s core business is heavily reliant on Medicaid, accounting for more than half of its revenue. The remaining portion is divided between Medicare and Marketplace plans. While analysts don’t anticipate the federal cuts to drastically reduce Centene’s overall revenue, they signal a period of significant challenges. London is responding by aggressively transforming the company’s portfolio, technology infrastructure, and internal culture. Since becoming CEO in 2022, she has focused on streamlining operations and shedding non-core assets.
A key component of London’s strategy is leveraging data and technology to better manage the health risks of its patient population, which tends to be sicker than that of many other insurers. The “One-CenTeam” initiative, launched under her leadership, aims to position Centene as a catalyst for healthier communities. In May 2024, at the Fortune Brainstorm Health conference, London announced a $900 million investment in affordable housing across eight states, recognizing the critical link between housing stability and health outcomes. This initiative underscores a broader focus on preventive health measures designed to reduce costly medical interventions.
From Storytelling to Systems Thinking
London’s path to leading a Fortune 500 company was unconventional. After earning a degree in history and literature from Harvard University, she spent two years in the film industry before realizing she wanted to make a more substantial social impact. She then held positions at Harvard, supporting health, education, and equity initiatives, and at the nonprofit Health Leads, where she helped refine its community-based care model. She later earned an MBA from the University of Chicago, shifting her focus from storytelling to “systems thinking,” using data to drive meaningful change.
Her commitment to data-driven healthcare led her to Humedica, a pioneer in leveraging big data in public health. Former CEO Michael Weintraub recalls London’s proactive approach when she contacted him in 2011. “Sarah sort of cold-called me,” Weintraub said. “It wasn’t, ‘Hi, hello.’ It was, ‘I researched your company; this is what I work on. I’ve heard about your team; this is who I want to work with.’ We made a decision to hire her that day.”
London rose through the ranks at Humedica, which was later acquired by UnitedHealth Group’s Optum, before joining Centene in 2020. She assumed the role of CEO in 2022 following the departure of longtime CEO Michael Neidorff shortly before his death. Neidorff had transformed Centene from a regional Medicaid plan with $40 million in annual revenue into the nation’s largest Medicaid managed care organization. London acknowledges that this rapid growth led to some operational inefficiencies, and she has prioritized streamlining the company’s structure.
A Holistic Approach to Vulnerable Populations
Despite the challenges posed by federal policy changes, London remains optimistic. She believes that the current reforms, while disruptive, also highlight the need for a more efficient and technologically advanced healthcare system. “You could capture a step back and come away with the conclusion that these [programs] are under attack,” she said, “But she notes that there was “quite a bit of bipartisan support” for making the sector more efficient.”
Centene is already implementing strategies to address these challenges, including work programs in over 17 states that partner with nonprofits to provide job training for Medicaid members. The company also utilizes sophisticated algorithms to detect fraud, waste, and abuse, running every claim through 75 algorithms daily. London emphasizes the need for a “digital revolution” in healthcare, pointing to initiatives such as supplemental food benefits in food deserts—recognizing the link between nutrition and medication adherence—and predictive algorithms to identify and support high-risk pregnancies. She notes that 41% of all babies born in the U.S. Are born onto Medicaid, underscoring the program’s crucial role in ensuring healthy outcomes for future generations.
London acknowledges the broader economic and health trends impacting the country. “The country is getting poorer and sicker,” she says. “The dollars are not infinite. At the finite boundaries, you have to make decisions about what you are going to fund and what you are not.”
The coming months will be critical as Centene navigates these complex challenges. The company is scheduled to report its next quarterly earnings in August, providing an updated assessment of the impact of the new federal policies and the effectiveness of its strategic initiatives. Investors and policymakers will be closely watching to observe how London and Centene adapt to this evolving healthcare landscape.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical or financial advice.
What are your thoughts on the future of Medicaid and the role of private insurers? Share your comments below and join the conversation.
Leave a Reply